Acadia Achieves Successful Late-Stage Study, But Narrow Beat Highlights One Big Potential Change Moving Forward – ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)


Acadia Pharmaceuticals (ACAD) announced that it had achieved positive results from a pivotal study known as ADVANCE using its drug pimavanserin to treat negative symptoms of schizophrenia. The initial market reaction was mixed, based on narrowly achieving statistical significance. However, an opportunity exists to move forward. On top of that,Read More →

EU trade chief eyes narrow path for U.S. trade talks By Reuters


© Reuters. EU Trade Commissioner Malmstrom attends an interview with Reuters in Geneva By David Lawder WASHINGTON (Reuters) – The European Union is focused on a narrower trade negotiation with the United States focused on industrial goods, including automobiles, European Trade Commissioner Cecilia Malmstrom said on Thursday, one day afterRead More →